ATE446301T1 - Ausgewählte kondensierte heterocyclen und deren anwendung - Google Patents

Ausgewählte kondensierte heterocyclen und deren anwendung

Info

Publication number
ATE446301T1
ATE446301T1 AT05771781T AT05771781T ATE446301T1 AT E446301 T1 ATE446301 T1 AT E446301T1 AT 05771781 T AT05771781 T AT 05771781T AT 05771781 T AT05771781 T AT 05771781T AT E446301 T1 ATE446301 T1 AT E446301T1
Authority
AT
Austria
Prior art keywords
application
condensed heterocycles
selected condensed
heterocycles
condensed
Prior art date
Application number
AT05771781T
Other languages
English (en)
Inventor
Brian Aquila
Michael Block
Audrey Davies
Jayachandran Ezhuthachan
Timothy Pontz
Daniel Russell
Marie-Elena Theoclitou
Xiaolan Zheng
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35004223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE446301(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE446301T1 publication Critical patent/ATE446301T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05771781T 2004-08-18 2005-08-16 Ausgewählte kondensierte heterocyclen und deren anwendung ATE446301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60239904P 2004-08-18 2004-08-18
PCT/GB2005/003202 WO2006018627A1 (en) 2004-08-18 2005-08-16 Selected fused heterocyclics and uses thereof

Publications (1)

Publication Number Publication Date
ATE446301T1 true ATE446301T1 (de) 2009-11-15

Family

ID=35004223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771781T ATE446301T1 (de) 2004-08-18 2005-08-16 Ausgewählte kondensierte heterocyclen und deren anwendung

Country Status (19)

Country Link
US (1) US20070249636A1 (de)
EP (1) EP1781673B1 (de)
JP (1) JP2008509976A (de)
KR (1) KR20070046175A (de)
CN (1) CN101023086A (de)
AR (1) AR050921A1 (de)
AT (1) ATE446301T1 (de)
AU (1) AU2005273704A1 (de)
BR (1) BRPI0514398A (de)
CA (1) CA2575056A1 (de)
DE (1) DE602005017283D1 (de)
IL (1) IL180811A0 (de)
MX (1) MX2007001954A (de)
NO (1) NO20070980L (de)
RU (1) RU2007109867A (de)
TW (1) TW200621260A (de)
UY (1) UY29074A1 (de)
WO (1) WO2006018627A1 (de)
ZA (1) ZA200701081B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781674A1 (de) 2004-08-18 2007-05-09 AstraZeneca AB Enantiomere von ausgewählten kondensierten pyrimidonen und anwendungen bei der behandlung und prävention von krebs
JP2008546843A (ja) * 2005-06-27 2008-12-25 アムゲン インコーポレイティッド 抗炎症性アリールニトリル化合物
PL2170340T3 (pl) * 2007-06-21 2016-06-30 Neuronascent Inc Sposoby i kompozycje stymulacji neurogenezy i hamowania degeneracji neuronów z wykorzystaniem izotiazolopirymidonów
HRP20160625T1 (hr) 2007-09-10 2016-08-12 Boston Biomedical, Inc. Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka
TW200934785A (en) 2007-10-19 2009-08-16 Schering Corp Compounds for inhibiting KSP kinesin activity
CA2908380A1 (en) 2013-04-09 2014-10-16 Boston Biomedical, Inc. Methods for treating cancer
WO2018102427A1 (en) 2016-11-29 2018-06-07 Boston Biomedical, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049527A2 (en) * 2001-12-06 2003-06-19 Merck & Co., Inc. Mitotic kinesin inhibitors
CA2468156A1 (en) * 2001-12-06 2003-06-19 Merck & Co., Inc. Azolopyrimidinone compounds and their use
NZ536190A (en) * 2002-04-17 2007-08-31 Cytokinetics Inc Compounds for treating cellular proliferative diseases by modulating the activity of the mitotic kinesin KSP
NZ542227A (en) * 2003-03-07 2008-12-24 Astrazeneca Ab Novel fused heterocycles and uses thereof
US7022850B2 (en) * 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
US7345046B2 (en) * 2003-05-30 2008-03-18 Chiron Corporation Heteroaryl-fused pyrimidinyl compounds as anticancer agents

Also Published As

Publication number Publication date
TW200621260A (en) 2006-07-01
CA2575056A1 (en) 2006-02-23
WO2006018627A1 (en) 2006-02-23
RU2007109867A (ru) 2008-09-27
UY29074A1 (es) 2006-03-31
US20070249636A1 (en) 2007-10-25
BRPI0514398A (pt) 2008-06-10
IL180811A0 (en) 2007-06-03
NO20070980L (no) 2007-03-12
EP1781673B1 (de) 2009-10-21
MX2007001954A (es) 2007-05-09
DE602005017283D1 (de) 2009-12-03
CN101023086A (zh) 2007-08-22
AR050921A1 (es) 2006-12-06
AU2005273704A1 (en) 2006-02-23
KR20070046175A (ko) 2007-05-02
EP1781673A1 (de) 2007-05-09
JP2008509976A (ja) 2008-04-03
ZA200701081B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DE602005025091D1 (de) Piezooszillator und herstellungsverfahren dafür
DE602005003186D1 (de) Fluorkopolymer und dessen Verwendung
HRP20220755T3 (hr) Anti-gm-csf antitijela i njihova uporaba
DE602006007831D1 (de) N-alkylcarbonylaminosäureester und n-alkylcarbonylaminosäurelaktonverbindungen und anwendung davon
EP1826209A4 (de) Nitromethylenderivate und deren verwendung
DE602004023760D1 (de) Kompositstent mit inneren und äusseren stentelementen und anwendungsverfahren
DE60321401D1 (de) Demodulationseinrichtung und demodulationsverfahren
EP1746902A4 (de) Multilektin-affiniätschromatografie und verwendung dafür
DE602006020061D1 (de) Mucin-glycoprotein und anwendung davon
DE602006012060D1 (de) Bicyclische bisamidderivate und deren anwendung als insektizide
ATE433448T1 (de) Kondensierte heterocyclen und deren verwendungen
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DE602005021959D1 (de) Substituierte diazaspiroä4.5üdecanderivate und der
ATE476500T1 (de) Neue phospholipasen und deren verwendungen
DE602006011600D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DE602005022751D1 (de) Gleitelement und herstellungsverfahren dafür
ATE493396T1 (de) Neue indazolcarboxamide und ihre verwendung
DE602006014957D1 (de) Audiocodierungseinrichtung und audiocodierungsverfahren
DE602005009200D1 (de) Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
ATE371653T1 (de) Benzoxazinderivate und deren verwendungen
DE60336025D1 (de) Kollimator und bestrahler
EP1829566A4 (de) Biofilmbildungshemmer und behandlungsvorrichtung
DE10338270B4 (de) Variator und Variatoranordnung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties